Development of a Cancer-Targeted Tissue-Specific Promoter System

Cancer Research

Volumn 64, Issue 1, 2004, Pages 363-369

  Fukazawa, Takuya ^a,c   Maeda, Yutaka ^b   Sladek, Frances M ^b   Owen Schaub, Laurie B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; SURFACTANT PROTEIN A; TELOMERASE REVERSE TRANSCRIPTASE; THYROID TRANSCRIPTION FACTOR 1;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE INSERTION; GENE THERAPY; GENETIC TRANSCRIPTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL; TARGET CELL; TISSUE SPECIFICITY;

CARCINOMA, LARGE CELL; CELL LINE, TUMOR; DEXAMETHASONE; DNA-BINDING PROTEINS; GENE THERAPY; GENES, REPORTER; HUMANS; LUCIFERASES; LUNG NEOPLASMS; PROMOTER REGIONS (GENETICS); TELOMERASE; TRANSFECTION;

EID: 1642576197     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2507     Document Type: Article

References (50)

1. Swisher, S. G., and Roth. J. A. p53 Gene therapy for lung cancer. Curr. Oncol. Rep., 4: 334-340, 2002.
2. Sung, M. W., Yeh, H. C., Thung, S. N., Schwartz, M. E., Mandeli, J. P., Chen, S. H., and Woo, S. L. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. Mol. Ther., 4: 182-191, 2001.
3. Fukazawa, T., Walter, B., and Owen-Schaub, L. B. Adenoviral Bid overexpression induces caspase-dependent tBid cleavage and p53-independent apoptosis in human non-small cell lung cancers. J. Biol. Chem., 278: 25428-25434, 2003.
4. Gu, J., Kagawa, S., Takakura, M., Kyo, S., Inoue, M., Roth, J. A., and Fang, B. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Cancer Res., 60: 5359-5364, 2000.
5. Gu, J., Zhang, L., Huang, X., Lin, T., Yin, M., Xu, K., Ji, L., Roth, J. A., and Fang, B. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Oncogene, 21: 4757-4764, 2002.
6. Greider, C. W. Chromosome first aid. Cell, 67: 645-647, 1991.
7. Kyo, S., Kanaya, T., Takakura, M., Tanaka, M., and Inoue, M. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int. J. Cancer. 80: 60-63, 1999.
8. Blasco, M. A., Funk, W. D., Villeponteau, B., and Greider, C. W. Functional characterization and developmental regulation of mouse telomerase RNA. Science (Wash. DC). 269: 1267-1270, 1995.
9. Ito, H., Kyo, S., Kanaya, T., Takakura, M., Inoue, M., and Namiki, M. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res., 4: 1603-1608, 1998.
10. Kanaya, T., Kyo, S., Takakura, M., Ito, H., Namiki, M., and Inoue, M. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int. J. Cancer, 78: 539-543, 1998.
11. Wright, W., Tesmer, V. M., Huffman, K. E., Levene, S. D., and Shay, J. W. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev., 21: 2801-2809, 1997.
12. Forsyth, N. R., Wright, W. E., and Shay, J. W. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation, 69: 188-197, 2002.
13. Gotubovskaya, V. M., Filatov, L. V., Behe, C. I., Presnell, S. C., Hooth, M. J., Smith, G. J., and Kaufmann, W. K. Telomere shortening, telomerase expression, and chromosome instability in rat hepatic epithelial stem-like cells. Mol. Carcinog., 24: 209-217, 1999.
14. Kotoula, V., Hytiroglou, P., Pyrpasopoulou, A., Saxena, R., Thung, S. N., and Papadimitriou, C. S. Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver, 22: 57-69, 2002.
15. Lee, H. W., Blasco, M. A., Gottlieb, G. J., Horner, J. W. 2nd, Greider, C. W., and DePinho, R. A. Essential role of mouse telomerase in highly proliferative organs. Nature (Lond.), 392: 569-574, 1998.
16. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science (Wash. DC), 282: 1145-1147, 1998.
17. Youssef, N., Paradis, V., Ferlicot, S., and Bedossa, P. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J. Pathol., 194: 459-465, 2001.
18. Adams, J. Y., Johnson, M., Sato, M., Berger, F., Gambhir, S. S., Carey, M., Iruela-Arispe, M. Li, and Wu, L. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat. Med., 8: 891-897, 2002.
19. Frankel, S., Smith, G. D., Donovan, J., and Neal, D. Screening for prostate cancer. Lancet, 361: 1122-1128, 2003.
20. Zhang, L., Adams, J. Y., Billick, E., Ilagan, R., Iyer, M., Le, K., Smallwood, A., Gambhir, S. S., Carey, M., and Wu, L. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol. Ther., 5: 223-232, 2002.
21. Wu, L., Matherly, J., Smallwood, A., Adams, J. Y., Billick, E., Belldegrun, A., and Carey, M. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther., 8: 1416-1426, 2001.
22. Maeda, Y., Seidel, S. D., Wei, G., Liu, X., and Sladek, F. M. Repression of hepatocyte nuclear factor 4á tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. Mol. Endocrinol., 16: 402-410, 2002.
23. Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., and Inoue, M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res., 59: 551-557, 1999.
24. Jiang, G., Nepomuceno, L., Hopkins, K., and Sladek, F. M. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol. Cell Biol., 15: 5131-5143, 1995.
25. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA, 95: 2509-2514, 1998.
26. Naar, A. M., Lemon, B. D., and Tjian, R. Transcriptional coactivator complexes. Annu. Rev. Biochem., 70: 475-501, 2001.
27. Rachez, C., and Freedman, L. P. Mediator complexes and transcription. Curr. Opin. Cell Biol., 3: 274-280, 2001.
28. Zamecnik, J., and Kodet, R. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch., 440: 353-361, 2002.
29. Bruno, M. D., Bohinski, R. J., Huelsman, K. M., Whitsett, J. A., and Korfhagen, T. R. Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J. Biol. Chem., 270: 6531-6536, 1995.
30. Hamdan, H., Liu, H., Li, C., Jones, C., Lee, M., deLemos, R., and Minoo, P. Structure of the human Nkx2.1 gene. Biochim. Biophys. Acta, 1396: 336-348, 1998.
31. Kuroki, Y., and Voelker, D. R. Pulmonary surfactant proteins. J. Biol. Chem., 269: 25943-25946, 1994.
32. Weaver, T. E., and Whitsett, J. A. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem. J., 273: 249-264, 1991.
33. Phelps, D. S., and Floros, J. Localization of pulmonary surfactant proteins using immunohistochemistry and tissue in situ hybridization. Exp. Lung. Res., 17: 985-995, 1991.
34. McCormick, S. M., Boggaram, V., and Mendelson, C. R. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes. Am. J. Physiol., 266: 354-366, 1994.
35. Li, J., Gao, E., Seidner, S. R., and Mendelson, C. R. Differential regulation of baboon SP-A1 and SP-A2 genes: structural and functional analysis of 5′-flanking DNA. Am. J. Physiol., 275: 1078-1088, 1998.
36. Hoover, R. R., Thomas, K. H., and Floros, J. Glucocorticoid inhibition of human SP-A1 promoter activity in NCI-H441 cells. Biochem. J., 340: 69-76, 1999.
37. Karinch, A. M., Deiter, G., Ballard, P. L., and Floros, J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture. Biochim. Biophys. Acta, 16: 192-202, 1998.
38. Kumar, A. R., and Snyder, J. M. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am. J. Physiol., 274: 177-185, 1991.
39. Smith, M. J., Rousculp, M. D., Goldsmith, K. T., Curiel, D. T., and Garver, R. I. Jr. Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. Hum. Gene Ther., 5: 29-35, 1994.
40. Shay, J. W., and Wright, W. E. Telomerase: a target for cancer therapeutics. Cancer Cell, 2: 257-265, 2002.
41. Minna, J. D., Roth, J. A., and Gazdar, A. F. Focus on lung cancer. Cancer Cell, 1: 49-52, 2002.
42. Yi, M., Tong, G. X., Murry, B., and Mendelson, C. R. Role of CBP/p300 and SRC-1 in transcriptional regulation of the pulmonary surfactant protein-A (SP-A) gene by thyroid transcription factor-1 (TTF-1). J. Biol. Chem., 4: 2997-3005, 2002.
43. Ahmed, T., Lutton, J. D., Feldman, E., Tani, K., Asano, S., and Abraham, N. G. Gene transfer of á-interferon into hematopoietic stem cells. Leuk. Res., 22: 119-124, 1998.
44. + cells and CML mononuclear cells. Stem Cells, 15: 386-395, 1997.
45. Mitani, K., Wakamiya, M., Hasty, P., Graham, F. L., Bradley, A., and Caskey, C. T. Gene targeting in mouse embryonic stem cells with an adenoviral vector. Somat. Cell Mol. Genet., 21: 221-231, 1995.
46. Hoffman, R. Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol., 3: 546-556, 2002.
47. Greco, O., Scott, S. D., Marples, B., and Dachs, G. U. Cancer gene therapy: "delivery, delivery, delivery." Front. Biosci., 7: 1516-1524, 2002.
48. Check, E. Second cancer case halts gene-therapy trials. Nature (Lond.), 421: 305, 2003.
49. Zoltick, P. W., and Wilson, J. M. Regulated gene expression in gene therapy. Ann. N. Y. Acad. Sci., 953: 53-63, 2001.
50. Kouretas, D., Karinch, A. M., Rishi, A., Melchers, K., and Floros, J. Conservation analysis of rat and human SP-A gene identifies 5′ flanking sequences of rat SP-A that bind rat lung nuclear proteins. Exp. Lung Res., 19: 485-503, 1993.